JP2005526713A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526713A5
JP2005526713A5 JP2003561587A JP2003561587A JP2005526713A5 JP 2005526713 A5 JP2005526713 A5 JP 2005526713A5 JP 2003561587 A JP2003561587 A JP 2003561587A JP 2003561587 A JP2003561587 A JP 2003561587A JP 2005526713 A5 JP2005526713 A5 JP 2005526713A5
Authority
JP
Japan
Prior art keywords
ambroxol
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526713A (ja
Filing date
Publication date
Priority claimed from DE10203104A external-priority patent/DE10203104A1/de
Application filed filed Critical
Publication of JP2005526713A publication Critical patent/JP2005526713A/ja
Publication of JP2005526713A5 publication Critical patent/JP2005526713A5/ja
Pending legal-status Critical Current

Links

JP2003561587A 2002-01-25 2003-01-21 慢性的疼痛、興奮毒性に関連した脳障害及び心臓不整脈の治療へのアンブロキソールの使用 Pending JP2005526713A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10203104A DE10203104A1 (de) 2002-01-25 2002-01-25 Ambroxol für die Behandlung chronischer Schmerzen
PCT/EP2003/000531 WO2003061642A1 (de) 2002-01-25 2003-01-21 Verwendung von ambroxol zur behandlung von chronischen schmerzen, cerebralen exzitotoxizitätsbedingten störungen und kardialen arrhythmien

Publications (2)

Publication Number Publication Date
JP2005526713A JP2005526713A (ja) 2005-09-08
JP2005526713A5 true JP2005526713A5 (https=) 2006-03-09

Family

ID=7713171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561587A Pending JP2005526713A (ja) 2002-01-25 2003-01-21 慢性的疼痛、興奮毒性に関連した脳障害及び心臓不整脈の治療へのアンブロキソールの使用

Country Status (11)

Country Link
EP (1) EP1471899B1 (https=)
JP (1) JP2005526713A (https=)
AR (1) AR038316A1 (https=)
AT (1) ATE376416T1 (https=)
CA (1) CA2473885C (https=)
DE (2) DE10203104A1 (https=)
ES (1) ES2295588T3 (https=)
PE (1) PE20040176A1 (https=)
TW (1) TW200307534A (https=)
UY (1) UY27620A1 (https=)
WO (1) WO2003061642A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332487A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
DE10332473A1 (de) * 2003-07-16 2005-02-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von Epilepsie
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
JP6871400B2 (ja) 2016-11-14 2021-05-12 ミングゥ・ワン 眼表面疾患の治療のための製剤および関連方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
CN1220598A (zh) * 1996-05-02 1999-06-23 大正制药株式会社 水难溶性酸性药物的悬浮液
JP2000080034A (ja) * 1998-09-02 2000-03-21 Taisho Pharmaceut Co Ltd 風邪用組成物
JP2001151677A (ja) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd 咽頭用組成物

Similar Documents

Publication Publication Date Title
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
ES2719900T3 (es) Combinación farmacéutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y pregabalina o gabapentina
FI3908270T3 (fi) Faanin ja bupropionin yhdistelmä masennuksen hoitoon aasialaisilla potilailla
HRP20120798T1 (hr) Kappa-opijatni agonisti za lijeäśenje dijareja-predominantnog i naizmjeniäśnog sindroma iritabilnog crijeva
FI3716979T3 (fi) 4-pyrimidiinisulfamidijohdannaisen ja SGLT-2-inhibiittorin yhdistelmä endoteliiniin liittyvien sairauksien hoitamiseksi
EP2251007A3 (en) Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases
JP2010502564A5 (https=)
JP2006501240A5 (https=)
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
JP2005512995A5 (https=)
WO2009127974A3 (ko) 심혈관계 질환 치료용 약제학적 제제
ATE332138T1 (de) Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
JP2005508963A5 (https=)
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
JP2023156344A5 (https=)
JP2005507892A5 (https=)
ES2313330T3 (es) Derivados de alfa-aminoamida utiles en el tratamiento del sindrome de piernas inquietas.
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
JPWO2021202419A5 (https=)
JP2005526713A5 (https=)
BRPI0408295A (pt) uso de um composto
EP4364738A3 (en) Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
CA2473885A1 (en) Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
CA2474430A1 (en) A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure